Christina Coghlan
CEO
Replay available
Avacta Group Plc (LSE: AVCT) Q2 2024 earnings conference call, held 2024-09-30. Replay captured from the company's public earnings webcast.

CEO
Watch the replay and follow the connected company analysis, news, and investor updates for Avacta Group Plc.
WEBVTT 00:00:00.031 -- 00:00:03.695 Good morning and welcome to the Evactor Group PLC investor presentation. 00:00:03.695 -- 00:00:06.577 To wrap this recorded meeting, investors will be in listen-only mode. 00:00:06.577 -- 00:00:10.401 Questions can be submitted at any time via the Q&A tab situated on the right-hand corner 00:00:10.401 -- 00:00:13.424 of your screen. Simply type in your question and press send. 00:00:13.424 -- 00:00:16.687 Due to the number of attendees on today's meeting, the company may not be in a position 00:00:16.687 -- 00:00:19.190 to answer every question received during the meeting itself. 00:00:19.190 -- 00:00:22.133 However, the company can review all questions submitted today and will publish responses 00:00:22.133 -- 00:00:26.797 where appropriate to do so. Before we begin, we'd like to submit the following poll. 00:00:26.797 -- 00:00:29.039 I'd now like to hand you to Christina Coghlan, CEO. 00:00:29.039 -- 00:00:31.360 Good morning. 00:00:31.486 -- 00:00:36.535 Good morning, Mark. Thank you for hosting and looking forward 00:00:36.535 -- 00:00:39.200 to the conversation. 00:00:39.200 -- 00:00:44.930 My name is Christina Coughlin, and I am the CEO of AVACTA. 00:00:44.930 -- 00:00:50.200 We are here today to present our interim results for the period ending 30th of June 00:00:50.200 -- 00:00:56.267 2024, and we are here as well for the business updates. 00:00:58.283 -- 00:01:04.248 We're going to start with the interim financial results for the EVACTA group. 00:01:05.071 -- 00:01:10.137 Key messages in the financial results published this morning is that the performance 00:01:10.137 -- 00:01:13.901 of the group was in line with board expectations. 00:01:13.901 -- 00:01:18.707 We have increased revenue and gross profit of the diagnostics ...